NASDAQ : AARD

Aardvark Therapeutics, Inc. Common Stock — Institutional Ownership

$7.52 USD

$0.29 (4.01%)

Volume
190.61K
Average Volume
263.97K
Market Capitalization
$164.57M
P/E Ratio
-2.34
Dividend Yield
0.00%
Price Target
$4.50
Year High
$17.94
Year Low
$3.35
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.06
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2025-05-15 Tien-Li Lee 2.98M 13.70%
2025-02-24 Citadel Advisors LLC 1.15M 5.40%
2025-02-24 Decheng Capital Global Life Sciences Fund IV, L.P. 2.96M 13.80%
2025-02-24 Dr. Finian Tan 1.83M 8.69%
AARD Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $13.13 21.82M $286.44M $47.05M $441K $239.83M
2024-12-31 $14.31 21.7M $310.47M $61.64M $779K $249.61M
2023-12-31 $14.31 21.38M $306.01M $9.74M $162K $296.44M
2022-12-31 $14.31 21.38M $306.01M $15.56M $262K $290.71M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $3.77 21.82M $82.25M $62.44M $336K $20.15M
2025-12-31 $13.13 21.82M $286.44M $47.05M $441K $239.83M
2025-09-30 $13.29 21.75M $288.99M $39.28M $545K $250.25M
2025-06-30 $13.52 21.69M $293.29M $26M $645K $267.94M
2025-03-31 $7.51 21.69M $162.88M $26.5M $726K $137.1M
2024-12-31 $14.31 21.7M $310.47M $61.64M $779K $249.61M
2024-09-30 $14.31 21.38M $306.01M $82.28M $868K $224.6M
2024-06-30 $14.31 21.38M $306.01M $86.17M $108K $219.95M
2024-03-31 $14.31 21.38M $306.01M -$ -$ $306.01M
2023-12-31 $14.31 21.38M $306.01M $9.74M $162K $296.44M
2023-09-30 $14.31 21.38M $306.01M -$ -$ $306.01M